Treatment of migraine with rizatriptan: When to take the medication

Headache

Volumn 42, Issue 1, 2002, Pages 16-20

  Hu, X Henry ^a   Raskin, Neil H ^b   Cowan, Robert ^c   Markson, Leona E ^a   Berger, Marc L ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Acute treatment; Migraine; Patient outcomes; Timing of medication

Indexed keywords

RIZATRIPTAN;

ARTICLE; DRUG EFFICACY; DRUG TOLERABILITY; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MIGRAINE; PAIN ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT OUTCOME;

DRUG ADMINISTRATION SCHEDULE; HUMANS; MIGRAINE DISORDERS; PROSPECTIVE STUDIES; SEROTONIN AGONISTS; SEVERITY OF ILLNESS INDEX; TRIAZOLES; TRYPTAMINES;

EID: 0036166604     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2002.02008.x     Document Type: Article

References (7)

1. Effect of early intervention with sumatriptan on migraine pain: Retrospective analyses of data from three clinical trials
2. Subcutaneous sumatriptan during the migraine aura
3. 1D agonist, prevent migraine headache when taken during an aura?
4. Which properties do patients expect of new and improved drugs in the treatment of primary headache disorders?
5. Stratified care vs step care strategies for migraine: The Disability in Strategies of Care (DISC) Study: A randomized trial